| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5Z93L87A1R |
| InChI Key | UYTPUPDQBNUYGX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C5H5N5O |
| Molecular Weight | 151.13 |
| AlogP | -0.77 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 100.45 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 11.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 11500 | - | - | 88 | |
|
Enzyme
Transferase
|
- | 5000 | 120-3300 | 5000 | 48 | |
|
Secreted protein
|
- | 11500 | - | - | 88 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Lymphoma, T-Cell, Cutaneous | 1 | D016410 | ClinicalTrials |
| Sezary Syndrome | 1 | D012751 | ClinicalTrials |
| Mycosis Fungoides | 1 | D009182 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 16235 |
| ChEMBL | CHEMBL219568 |
| DrugBank | DB02377 |
| EPA CompTox | DTXSID9052476 |
| FDA SRS | 5Z93L87A1R |
| Human Metabolome Database | HMDB0000132 |
| Guide to Pharmacology | 4556 |
| KEGG | C00242 |
| PDB | GUN |
| PubChem | 135398634 |
| SureChEMBL | SCHEMBL5259 |
| ZINC | ZINC000000895129 |